Russell Frank Company’s Elevance Health ELV Stock Holding History

Russell Frank Company’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$238M	Sell	1,714,288 -16,156	-0.9%	-$2.16M	0.42%	32
2015 Q4	$244M	Buy	1,730,444 +208,030	+14%	+$28.7M	0.43%	32
2015 Q3	$213M	Buy	1,522,414 +39,455	+3%	+$5.93M	0.4%	42
2015 Q2	$243M	Buy	1,482,959 +322,376	+28%	+$51.5M	0.39%	41
2015 Q1	$179M	Sell	1,160,583 -107,118	-8%	-$15.3M	0.33%	54
2014 Q4	$159M	Sell	1,267,701 -102,952	-8%	-$12.7M	0.28%	74
2014 Q3	$164M	Sell	1,370,653 -65,473	-5%	-$7.51M	0.29%	69
2014 Q2	$161M	Sell	1,436,126 -253,475	-15%	-$26.1M	0.28%	79
2014 Q1	$162M	Sell	1,689,601 -184,037	-10%	-$16.6M	0.28%	75
2013 Q4	$162M	Sell	1,873,638 -16,424	-0.9%	-$1.46M	0.3%	70
2013 Q3	$158M	Sell	1,890,062 -170,655	-8%	-$14.6M	0.28%	75
2013 Q2	$169M	Buy	+2,060,717	New	+$154M	0.31%	64

Other funds holding ELV

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Russell Frank Company's ELV Position: Q1 2016 in Review

Russell Frank Company reduced its Elevance Health (ELV) stake by 0.93% in Q1 2016, selling an estimated $2.16M and leaving 1,714,288 shares worth $238M. The position accounts for 0.42% of the portfolio, ranked #32.

Russell Frank Company first reported a position in ELV in Q2 2013 and has held it in 12 quarters since. The position peaked at $244M in Q4 2015. 770 funds tracked by Wall St. Rank hold ELV as of Q1 2016.

Russell Frank Company held 1,714,288 shares of Elevance Health worth $238M as of Q1 2016.
Russell Frank Company sold 16,156 Elevance Health shares in Q1 2016, an estimated $2.16M.
Elevance Health made up 0.42% of Russell Frank Company's portfolio in Q1 2016, its #32 holding.
Russell Frank Company first reported a position in Elevance Health in Q2 2013 and has held it in 12 quarters since.
Russell Frank Company's Elevance Health position peaked at $244M in Q4 2015.
770 funds tracked by Wall St. Rank held Elevance Health as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.